CRTX Financial Facts
Weighted-average common shares, diluted: 30.97MNet income (loss) per share, basic: 0.09
See Full Income Statement
Retained earnings: 1.1M
Property and equipment, net: 1.49M
See Full Balance Sheet
Earnings History for Cornerstone Therapeutics Inc. (CRTX)
|
Expand Research on CRTX
| Next EPS Date | 5/13/13 *Est. | EPS Growth Rate | -333.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -300.2% | Revenue Growth Rate | +91.8% *Last Qtr. |
| Average % Move 1-Wk after EPS | +5.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/14/13 | Q412 | -$0.26 | $0.10 | -$0.36 | $34.93M | $36.04M | N/A / N/A | N/A | +26.2% | Details | |
| 11/8/12 | Q312 | $0.19 | $0.32 | -$0.13 | $37.5M | $32M | N/A / N/A | N/A | +87.5% | Details | |
| 8/9/12 | Q212 | -$0.17 | -$0.02 | -$0.15 | $21.47M | $18.84M | N/A / N/A | N/A | +36.8% | Details | |
5/15/12  |
Q112 | $0.05 | $0.10 | -$0.05 | $22.2M | $20M | N/A / N/A | N/A | 0% | Details | |
| 3/8/12 | Q411 | -$0.06 | $0.09 | -$0.15 | $18.21M | $24.58M | N/A / N/A | N/A | +83.7% | Details | |
| 11/3/11 |
 |
Q311 | $0.13 | $0.14 | -$0.01 | $25.18M | $28.39M | N/A / N/A | N/A | +38.2% | Details |
| 8/4/11 |
|
Q211 | $0.11 | $0.06 | +$0.05 | $28.04M | $25.71M | N/A / N/A | N/A | +14.4% | Details |
| 5/12/11 |
|
Q111 | $0.17 | $0.15 | +$0.02 | $29.98M | $29.63M | N/A / N/A | N/A | +31% | Details |
